Clinical Trials Support

Clinical Trial Support Services

Automated Whole Blood Fractionation

Data Integrity

Consistent sample processing is critical for biomarker-driven assays, as the result can be sensitive to pre-analytical variables. Scorpion safeguards the integrity of biomarker assay data through the use of an automated system that enables fast and gentle isolation of any cell subset from whole blood. The autoMACS® Pro Separator provides a robust, standardized whole blood and PBMC processing fractionation.

Sample Processing Capabilities:

  • PBMC (peripheral blood mononuclear cell) isolations, cryopreservation, characterization, and same-day or next-day processing
  • Blood fractionation for isolation of serum, plasma, and multiple cell types
  • Quantity, quality, and purity assessment of cell subsets
  • Custom processing studies
  • Standardized SOPs for laboratory services (customizable on demand)

Scorpion's autoMACS® Pro Separator

The autoMACS® Pro Separator enables fast and gentle isolation of virtually any cell type, ideal for downstream applications like flow cytometry.

Our Technologies

Clinical PK / Bioavailability Studies

Determining Drug Exposure

Pharmacokinetic (PK) studies provide the basis for determining drug exposures in the body over time. PK parameters are used in the evaluation of the absorption, distribution, metabolism, and excretion (ADME) processes of drugs. Scorpion develops and validates bioanalytical methods in human biological matrices to provide pharmacokinetic data during clinical trials.

Bioanalytical Methods

Our highly experienced team of scientists can develop robust bioanalytical methods and calculate PK parameters by non-compartmental analysis (NCA) to support PK studies for the analysis of drugs and metabolites in biological fluids. We have implemented validated software for NCA, enabling the generation of formal reports satisfying regulatory agency requirements.

PK / PD Analysis

Relationship of Exposure and Efficacy

Pharmacokinetics (PK) describes the fate of a therapeutic in the living organism, while pharmacodynamics (PD) studies the relationship between drug concentration at the site of action and the observed pharmacological response. PK/PD analysis provides the relationship between the drugs’ in vivo exposure and efficacy. Scorpion can provide interpretation of PK/PD data for all phases of clinical study using our in-house validated software.

Compartmental & non-compartmental analysis using WinNonlin® software:

  • Bioavailability/Bioequivalence
  • PK/PD analysis
  • Statistical analysis (SAS®)
  • Prediction of human PK via allometric scaling and in vitro scale-up

Immunogenicity Testing

Measuring Adverse Immune Responses

Immunogenicity testing measures any adverse immune response generated by a biologic, such as reduced efficacy or autoimmune, allergic, and anaphylactic reactions in the body. Scorpion scientists offer deep expertise in anti-drug antibody (ADA) assays (screening, confirmation, and titration).

Immunogenic Responses

We develop ADA assays to reliably measure and validate immunogenic responses in a variety of biological matrices for your regulatory filing. We offer Biacore and ELISA-based immunogenicity assay development and validation to quantitate the unique ADA effects of antibodies, recombinant proteins, peptides, etc.

Scorpion has extensive experience designing, validating, and optimizing immunogenicity assays according to regulatory guidelines and can provide support in developing screening methods to measure immunogenicity, followed by titer and confirmation assays.

We use FDA-recommended multi-step approaches to measure ADA response to your drug candidate:

  • Screening
  • Confirmation
  • Titer Determination

All confirmed ADA-positive samples are tested for neutralizing antibodies using Neutralizing Antibody (NAb) assays.

Flow Cytometry-Based Assays

High-Throughput Quantitative Analysis

Immunotherapeutic product development requires high throughput and robust quantitative analysis of the immune system in the tumor micro-environment, peripheral blood, and other host tissues. To meet this need, Scorpion offers state-of-the-art analytical flow cytometry.

Highly multiplexed immunophenotyping of surface and intracellular marker combinations for monitoring immune biomarkers in humans

  • Scorpion has developed a standard set of surface marker panels for immunophenotyping and can custom design panels as needed.

Intracellular cytokine staining

  • A short-term consequence of immune cell activation is the production of cytokines by responsive cells. The frequency of responsive cells and the types of cytokines they produce can be useful biomarkers for monitoring immune responses to vaccines or specific antigens, or to monitor immune function as related to disease progression.

MHC-peptide tetramer assays for direct visualization and quantification of antigen-specific T cells

  • Samples, like PBMCs or whole blood, mixed with MHC-peptide tetramers, can be analyzed via flow cytometry to detect, and sort CD4+ or CD8+ T cells that are specific for peptide antigens of interest. Meanwhile, the flow cytometric signal can also determine the existence and the strength of some cell-mediated immune response to a certain pathogen from which the antigen peptide derives.

Tetramers that will provide a wider base of HLA molecules and enable them to be combined more effectively with functional assays

  • The use of combinational approaches, both for production of tetramers and for flow cytometric analysis, will provide in-depth characterization, breadth, and functional data.

Functional Immune Profiling

Understanding Immune Changes

Scorpion offers a comprehensive approach for analysis of immune functions in humans. Application of immunoprofiling, in the context of clinical studies, allows investigators to understand immune changes that might happen in healthy individuals, those that occur with environmental exposure, and the connection between the human immune system and disease.